Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Essential Healthcare News.
Press releases published on April 30, 2025

NeuroSigma Announces New Clinical Trial of Monarch eTNS System for Treatment of ADHD in Children with Fetal Alcohol Syndrome at UCLA
Trial to be conducted at UCLA and funded by a grant from National Institute on Alcohol Abuse and Alcoholism (NIAAA) First phase of trial will enroll up to 30 children ages 8 – 12 with exposure to alcohol during gestation to receive treatment with the …

Arialief Reviews (DOCTOR INVESTIGATION REVEALS) Natural, Science-Backed Relief for Chronic Pain & Inflammation
FINDLAY, Ohio, April 30, 2025 (GLOBE NEWSWIRE) -- Introduction: Understanding Nerve Pain and the Promise of Arialief Millions of people worldwide suffer silently from nerve pain — a condition that slowly steals mobility, independence, and quality of life. …

WellSpan Surgery and Rehabilitation Hospital reaccredited with top Magnet designation
York, Pa., April 30, 2025 (GLOBE NEWSWIRE) -- WellSpan Surgery and Rehabilitation Hospital in York has been reaccredited as a Magnet hospital, the highest honor for nursing, awarded by the American Nurses Credentialing Center (ANCC). As part of the …

Spark Biomedical Secures $15M Series A To Advance Drug-Free Wearable Neurostimulation Therapies
Dallas, TX, April 30, 2025 (GLOBE NEWSWIRE) -- Spark Biomedical, a leading health tech innovator in wearable neurostimulation technology, has closed its $15M Series A round—led by WAVE Ventures and supported by Pathway to Cures—to accelerate the …

X-Chem Expands Strategic Collaboration With Orion Pharma to Accelerate Orion’s Early Drug Discovery From Hit to Candidate
WALTHAM, Mass., April 30, 2025 (GLOBE NEWSWIRE) -- X-Chem, a global leader in DNA-encoded library (DEL) technology and data-driven drug discovery, has announced an expanded collaboration with Orion Pharma. The agreement builds on an existing relationship …

ScribeAmerica to Showcase Provider Enablement Solutions at UCA’s 2025 Urgent Care Convention
FORT LAUDERDALE, FLORIDA, April 30, 2025 (GLOBE NEWSWIRE) -- ScribeAmerica is proud to announce its participation in the 2025 Urgent Care Convention, taking place May 2-6 in Dallas, TX. The company will exhibit in the Solutions. Expo at booth #1019, where …

BioSyent to Present at 2025 Bloom Burton & Co. Healthcare Investor Conference
MISSISSAUGA, Ontario, April 30, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that it will be presenting at the upcoming 2025 Bloom Burton …

Corporate Update
Boston, MA, April 30, 2025 (GLOBE NEWSWIRE) -- Vystar® Corporation (OTCQB: VYST) Vystar received notice of final approval of its Form 15C-211 application. In addition, today the Company moved from the Pink Sheets to the OTCQB Exchange. The Company …

HLTH 2025 Launches Groundbreaking New Experiences in AI, Pharma, and Diagnostics – While Returning Classics Get a Fresh Twist
LAS VEGAS, April 30, 2025 (GLOBE NEWSWIRE) -- HLTH Inc., the catalyst for global healthcare innovation, returns to Las Vegas on October 19–22, 2025, with a bold new agenda designed to redefine the future of healthcare. Led by new, immersive marketplaces …

Best Male Enhancement Pills – Top Natural Male Enhancement Supplements & Gummies: Erectin Under Review By Leading Edge Health
Limassol, Cyprus, April 30, 2025 (GLOBE NEWSWIRE) -- Every man wants to perform like a stud in the bedroom and beyond. We’d like to wield powerful erections, climax with massive force, last all night long, and leave our partners begging for more. The best …

Fifty 1 Labs, Inc. Accelerates Growth with New CEO, BioSentry Division Launch and Shareholder Dividend; Company Pursues Strategic Growth Through UAV Partnership and Targeted Acquisitions in Advanced Tech and Wellness
MELBOURNE, Fla., April 30, 2025 (GLOBE NEWSWIRE) -- via IBN -- Fifty 1 Labs, Inc. (OTC: FITY), a leader in innovative technology and wellness solutions, is thrilled to announce that Michael Lawson has assumed the roles of Chief Executive Officer and …

AAPA 2025 Salary Report: Rising Compensation Confirms PA Profession’s Vital Role in Healthcare System
Alexandria, Va., April 30, 2025 (GLOBE NEWSWIRE) -- The American Academy of Physician Associates (AAPA) has released the findings of its 2025 AAPA Salary Report, shedding light on key trends shaping the physician associate/assistant (PA) profession. …

INVO Fertility Announces 2024 Financial Results with 116% Annual Revenue Growth and Further Improvements in Adjusted EBITDA
SARASOTA, Fla., April 30, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO Fertility” or the “Company”), a healthcare services fertility company focused on expanding access to advanced treatment through the establishment, acquisition and …

Helius Medical Technologies Announces Reverse Stock Split
NEWTOWN, Pa., April 30, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, announced …

Senti Bio to Present at the Citizens JMP Life Sciences Conference
Live video webcast presentation on Thursday, May 8th at 1:00 PM ET Presentation will highlight the recently announced positive preliminary clinical results of lead program, SENTI-202, in the treatment of patients with Relapsed/Refractory AML SOUTH SAN …

InspireMD to Present at Upcoming Bank of America 2025 Healthcare Conference
MIAMI, April 30, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Prime carotid stent system for the treatment of carotid artery disease and prevention of stroke, today announced management will present at the Bank of …

PathAI to Present at Digestive Disease Week
BOSTON, April 30, 2025 (GLOBE NEWSWIRE) -- PathAI, a global leader in AI-powered pathology solutions, today announced it will present research from the outputs of IBD ExploreTM and AIM-HI UCTM at Digestive Disease Week (DDW) from May 3-6, 2025, in San …

Medicenna Presents Promising Preclinical Data from its First-in-Class Tumor Targeted and Conditionally Activated Anti-PD-1-IL-2 Bifunctional Superkine at the Annual 2025 AACR Meeting
MDNA113 is a novel IL-13Rα2 tumor-targeted and “masked” anti-PD-1-IL-2 Superkine (anti-PD1-IL-2SK), engineered to precisely deliver clinically validated anti-PD1 and IL-2SK to the tumor microenvironment (TME) IL-13Rα2 is overexpressed by some of the most “ …

PharmAla Issues Q2 Financial Statements
TORONTO, April 30, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC: MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel derivatives of MDMA …

Elligint Health Partners with CareCo to Transform Care Coordination and Utilization Management with Advanced AI Workflow Tools and Integrated AI-Powered VoIP System
KINGSTON, Pa., April 30, 2025 (GLOBE NEWSWIRE) -- Elligint Health, parent company of VirtualHealth, is excited to announce a strategic partnership with CareCo to deliver next-generation healthcare solutions. This groundbreaking collaboration will integrate …